GIRH Chronic Obstructive Pulmonary Disease Observational Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-10

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to establish the large COPD cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

NCT03170999

Airway Obstruction

COMPLETED

A Cohort of Patients With Chronic Pulmonary Disease

NCT04050943

Obstructive Pulmonary Disease

UNKNOWN

Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China

NCT04853238

Pulmonary Disease, Chronic Obstructive

COMPLETED

Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China

NCT04853225

Pulmonary Disease, Chronic Obstructive

COMPLETED

The Cohort Study for Chronic Obstructive Pulmonary Disease (COPD) in China

NCT03044847

Pulmonary Disease, Chronic Obstructive

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pulmonary function

Intervention Type OTHER

this is a observation study, no any intervention in patients

biological sample detection outcome

Intervention Type OTHER

this is a observation study, no any intervention in patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

this is a observation study, no any intervention in patients

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-Aged 40-70 years COPD group: baseline post-bronchodilator FEV1/FVC \< 0.7 Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years

Exclusion Criteria

* Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc The usual criteria of serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months eye surgery in the last three months retinal detachment myocardial infarction in the last 3 months admission to hospital for any cardiac condition in the last month heart rate over 120 beats per minute antibacterial chemotherapy for tuberculosis pregnant or breast feeding

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes